MedTrace Logo

Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy

NCT01998074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-11-28

No results posted yet for this study

Summary

The aim of the study is to show the efficacy, tolerance and nutritional adequacy of a newly developed hydrolyzed rice formula in infants with a proven cow's milk protein allergy.

Conditions

  • Milk Hypersensitivity
  • Food Sensitivity
  • Protein Allergy

Interventions

DIETARY_SUPPLEMENT

extensively hydrolyzed rice protein formula

Sponsors & Collaborators

  • United Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Model
SINGLE_GROUP

Eligibility

Min Age
2 Weeks
Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2013-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01998074 on ClinicalTrials.gov